TY - JOUR
T1 - An association of particulate air pollution and traffic exposure with mortality after lung transplantation in Europe
AU - Ruttens, David
AU - Verleden, Stijn E.
AU - Bijnens, Esmee M.
AU - Winckelmans, Ellen
AU - Gottlieb, Jens
AU - Warnecke, Gregor
AU - Meloni, Federica
AU - Morosini, Monica
AU - van der Bij, Wim
AU - Verschuuren, Erik A.
AU - Sommerwerck, Urte
AU - Weinreich, Gerhard
AU - Kamler, Markus
AU - Roman, Antonio
AU - Gomez-Olles, Susana
AU - Berastegui, Cristina
AU - Benden, Christian
AU - Holm, AreMartin
AU - Iversen, Martin
AU - Schultz, Hans Henrik
AU - Luijk, Bart
AU - Oudijk, Erik-Jan
AU - Erp, Johanna M. Kwakkel-van
AU - Jaksch, Peter
AU - Klepetko, Walter
AU - Kneidinger, Nikolaus
AU - Neurohr, Claus
AU - Corris, Paul. A.
AU - Fisher, Andrew J.
AU - Lordan, James
AU - Meachery, Gerard
AU - Piloni, Davide
AU - Vandermeulen, Elly
AU - Bellon, Hannelore
AU - Hoffmann, Barbara
AU - Vienneau, Danielle
AU - Hoek, Gerard
AU - de Hoogh, Kees
AU - Nemery, Benoit
AU - Verleden, Geert M.
AU - Vos, Robin
AU - Nawrot, Tims.
AU - Vanaudenaerde, Bart M.
PY - 2017
Y1 - 2017
N2 - Air pollution from road traffic is a serious health risk, especially for susceptible individuals. Single-centre studies showed an association with chronic lung allograft dysfunction (CLAD) and survival after lung transplantation, but there are no large studies.13 lung transplant centres in 10 European countries created a cohort of 5707 patients. For each patient, we quantified residential particulate matter with aerodynamic diameter. 10 mu m (PM10) by land use regression models, and the traffic exposure by quantifying total road length within buffer zones around the home addresses of patients and distance to a major road or freeway.After correction for macrolide use, we found associations between air pollution variables and CLAD/ mortality. Given the important interaction with macrolides, we stratified according to macrolide use. No associations were observed in 2151 patients taking macrolides. However, in 3556 patients not taking macrolides, mortality was associated with PM10 (hazard ratio 1.081, 95% CI 1.000-1.167); similarly, CLAD and mortality were associated with road lengths in buffers of 200-1000 and 100-500 m, respectively (hazard ratio 1.0851.130). Sensitivity analyses for various possible confounders confirmed the robustness of these associations.Long-term residential air pollution and traffic exposure were associated with CLAD and survival after lung transplantation, but only in patients not taking macrolides.
AB - Air pollution from road traffic is a serious health risk, especially for susceptible individuals. Single-centre studies showed an association with chronic lung allograft dysfunction (CLAD) and survival after lung transplantation, but there are no large studies.13 lung transplant centres in 10 European countries created a cohort of 5707 patients. For each patient, we quantified residential particulate matter with aerodynamic diameter. 10 mu m (PM10) by land use regression models, and the traffic exposure by quantifying total road length within buffer zones around the home addresses of patients and distance to a major road or freeway.After correction for macrolide use, we found associations between air pollution variables and CLAD/ mortality. Given the important interaction with macrolides, we stratified according to macrolide use. No associations were observed in 2151 patients taking macrolides. However, in 3556 patients not taking macrolides, mortality was associated with PM10 (hazard ratio 1.081, 95% CI 1.000-1.167); similarly, CLAD and mortality were associated with road lengths in buffers of 200-1000 and 100-500 m, respectively (hazard ratio 1.0851.130). Sensitivity analyses for various possible confounders confirmed the robustness of these associations.Long-term residential air pollution and traffic exposure were associated with CLAD and survival after lung transplantation, but only in patients not taking macrolides.
KW - BRONCHIOLITIS OBLITERANS SYNDROME
KW - RANDOMIZED CONTROLLED-TRIAL
KW - PLACEBO-CONTROLLED TRIAL
KW - USE REGRESSION-MODELS
KW - ALLOGRAFT DYSFUNCTION
KW - DOUBLE-BLIND
KW - AZITHROMYCIN
KW - EXACERBATIONS
KW - PREVENTION
KW - NO2
U2 - 10.1183/13993003.00484-2016
DO - 10.1183/13993003.00484-2016
M3 - Article
SN - 0903-1936
VL - 49
JO - European Respiratory Journal
JF - European Respiratory Journal
IS - 1
ER -